Equity Briefing : Pluristem's PLX cells may change bone marrow transplantation ... Reuters CEO of Pluristem Therapeutics, Inc. (NASDAQCM:PSTI( (TASE: PLTR) tells shareholders that his firm's PLX cells may be effective in supporting bone marrow transplantation as well as other potential indications where bone marrow may be suppressed, ... |
